Primary nonresponse to anti-cd20 therapy in gastrointestinal posttransplant lymphoproliferative disorder.

作者信息

Gökçe Selim, Süoğlu Ozlem Durmaz, Sökücü Semra, Gün Feryal, Emiroğlu Haldun, Celik Alaaddin, Doğan Oner, Cevikbaş Uğur

机构信息

Department of Pediatric Gastroenterology, Hepatology and Nutrition, Istanbul University Istanbul School of Medicine, Istanbul, Turkey.

出版信息

J Pediatr Gastroenterol Nutr. 2006 Mar;42(3):316-20. doi: 10.1097/01.mpg.0000189333.85268.b9.

DOI:10.1097/01.mpg.0000189333.85268.b9

PMID:16540802

Abstract

摘要

相似文献

Primary nonresponse to anti-cd20 therapy in gastrointestinal posttransplant lymphoproliferative disorder.

J Pediatr Gastroenterol Nutr. 2006 Mar;42(3):316-20. doi: 10.1097/01.mpg.0000189333.85268.b9.

Monoclonal antibody therapy for posttransplant lymphoproliferative disorders.

Liver Transpl. 2000 Sep;6(5):657-8. doi: 10.1002/lt.500060520.

Post-transplant lymphoproliferative disorder treated with rituximab: case report.

Chin Med J (Engl). 2007 May 5;120(9):841-3.

Treatment of posttransplant lymphoproliferative disorder with the anti-CD20 monoclonal antibody rituximab alone in an adult after liver transplantation: a new drug in therapy of patients with posttransplant lymphoproliferative disorder after solid organ transplantation?

Transplantation. 2000 Feb 15;69(3):430-2. doi: 10.1097/00007890-200002150-00021.

High-intensity chemotherapy and rituximab for the treatment of posttransplant lymphoproliferative disorder.

Am J Clin Oncol. 2006 Apr;29(2):211-2. doi: 10.1097/01.coc.0000162640.27701.9f.

PTLD treatment: reducing the chemotherapy burden through addition of rituximab.

Pediatr Transplant. 2010 Feb;14(1):10-1. doi: 10.1111/j.1399-3046.2009.01289.x.

Intestinal perforation associated with rituximab therapy for post-transplant lymphoproliferative disorder after liver transplantation.

Cancer Chemother Pharmacol. 2009 Sep;64(4):857-60. doi: 10.1007/s00280-009-1062-1. Epub 2009 Jul 9.

Rituximab with peripheral blood stem cell transplantation in CD20 lymphoproliferative disorders.

Haematologica. 2001 Oct;86(10):1104-5.

AntiCD20 monoclonal antibody-based radioimmunotherapy of relapsed chemoresistant aggressive post-transplantation B-lymphoproliferative disorder in heart-transplant recipient.

Lancet Oncol. 2005 Aug;6(8):629-31. doi: 10.1016/S1470-2045(05)70286-2.

Management of patients with post-transplant lymphoproliferative disorder: the role of rituximab.

Transpl Int. 2006 Apr;19(4):259-69. doi: 10.1111/j.1432-2277.2006.00284.x.

引用本文的文献

Treatment with rituximab in benign and malignant hematologic disorders in children.

J Pediatr. 2007 Apr;150(4):338-44, 344.e1. doi: 10.1016/j.jpeds.2006.12.038.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验